There are limited treatment options for MM, and relapse and developing resistance against treatment drugs is a worrying trend in MM ( Anderson et al., 2009 ).
← all excerpts
Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications.
1
—
—